Agreed KBC. It appears that Omricon is peaking in N. America now and we won't have an application to Health Canada until June (or later as history shows) and how long will they take to review it? It might take almost to year end to have this available. I would like to think sooner but history doesn't align with that. It took almost a year to start the trial and is still taking time to dose more than in Edmonton. I don't know if Omricon is peaking in the Third World or not but Apabetalone will probably mostly miss N. America for it. Next variant?

If it was still useful in the Third World, it would boost the share price which would help financing prices and help world health but not contribute much for direct injection into RVX coffers as they would probably receive it at cost. I also don't know how Omricon is progressing in the Middle East where they have money to pay for it.

I hope things go faster but history doesn't bode well for it.